Anthem Biosciences States It Won't Launch Products Using Anti-Cancer Drug Alectinib: Delhi High Court
The Delhi High Court, in a significant development under the Patents Act, 1970, has recorded an undertaking by Anthem Biosciences Limited that it will not launch any product containing the anti-cancer compound Alectinib, or its salts, solvates, or intermediates, until the next date of hearing in an ongoing patent infringement case. Court Proceedings and Undertaking by Defendant During the proceedings, Justice Tejas Karia issued notice to the Bangalore-based pharmaceutical company,…
